Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athan Kuliopulos

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Life Sciences|November 11, 2003
Blocking receptors on the inside: pepducin-based intervention of PAR signaling and thrombosisAthan Kuliopulos, Lidija Covic
International Journal of Molecular Sciences|August 2, 2018
Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin ApproachLidija Covic, Athan Kuliopulos
The Biochemical Journal|September 19, 2003
Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavageSuzanne L Jacques, Athan Kuliopulos
Journal of Cellular Physiology|April 17, 2014
Mouse matrix metalloprotease-1a (Mmp1a) gives new insight into MMP functionCaitlin J Foley, Athan Kuliopulos
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2021
Lipopeptide Pepducins as Therapeutic AgentsEmily Michael, Lidija Covic, Athan Kuliopulos
Thrombosis and Haemostasis|December 8, 2004
Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregationAthan Kuliopulos, Ramon Mohanlal, Lidija Covic
The Journal of Biological Chemistry|March 1, 2012
Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug developmentKatie O'Callaghan, Athan Kuliopulos, Lidija Covic
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2015
Pepducins and Other Lipidated Peptides as Mechanistic Probes and TherapeuticsPing Zhang, Lidija Covic, Athan Kuliopulos
Blood|October 23, 2012
Matrix metalloproteases and PAR1 activationKaryn M Austin, Lidija Covic, Athan Kuliopulos
Circulation|September 6, 2006
Protease-activated receptors in cardiovascular diseasesAndrew J Leger, Lidija Covic, Athan Kuliopulos
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Life Sciences|November 11, 2003
Blocking receptors on the inside: pepducin-based intervention of PAR signaling and thrombosisAthan Kuliopulos, Lidija Covic
International Journal of Molecular Sciences|August 2, 2018
Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin ApproachLidija Covic, Athan Kuliopulos
The Biochemical Journal|September 19, 2003
Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavageSuzanne L Jacques, Athan Kuliopulos
Journal of Cellular Physiology|April 17, 2014
Mouse matrix metalloprotease-1a (Mmp1a) gives new insight into MMP functionCaitlin J Foley, Athan Kuliopulos
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2021
Lipopeptide Pepducins as Therapeutic AgentsEmily Michael, Lidija Covic, Athan Kuliopulos
Thrombosis and Haemostasis|December 8, 2004
Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregationAthan Kuliopulos, Ramon Mohanlal, Lidija Covic
The Journal of Biological Chemistry|March 1, 2012
Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug developmentKatie O'Callaghan, Athan Kuliopulos, Lidija Covic
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2015
Pepducins and Other Lipidated Peptides as Mechanistic Probes and TherapeuticsPing Zhang, Lidija Covic, Athan Kuliopulos
Blood|October 23, 2012
Matrix metalloproteases and PAR1 activationKaryn M Austin, Lidija Covic, Athan Kuliopulos
Circulation|September 6, 2006
Protease-activated receptors in cardiovascular diseasesAndrew J Leger, Lidija Covic, Athan Kuliopulos
Pageof 7